$FLSC

Cha Albert purchased $3.0M of FLSC (indirect holdings)

Cha Albert (Chief Executive Officer) purchased 300,000 indirectly-held shares of Frazier Life Sciences Acquisition Corp. II (FLSC) at $10.00 ($3.00M total) on 2026-10-15. Filed jointly with Frazier Life Sciences Holdings II LLC (10% owner), Frazier Life Sciences Public Fund, L.P. (10% owner), FHMLSP, L.P. (10% owner) and FHMLSP, L.L.C. (10% owner).

Original reporting
SEC EDGAR · Cha Albert, Frazier Life Sciences Holdings II LLC, Frazier Life Sciences Public Fund, L.P., FHMLSP, L.P., FHMLSP, L.L.C.
Published Oct 15, 2026, 8:40 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 8:42 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$FLSC
Bullish
medium confidence
Mentioned
$FLSC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FLSCBullishLow
01

Why it matters

This provides a new, primary datapoint on insider behavior, but it does not disclose new fundamentals, guidance, or corporate actions that would drive a major repricing.

02

Market read

Traders may treat the filing as a modest sentiment input, but it is unlikely to be a standalone catalyst for large price moves.

03

What to watch

The transaction is described as indirect and on an open-market purchase code, with no 10b5-1 plan cited, so traders should avoid over-weighting it versus any concurrent corporate developments.

Relevance 7/10Novelty 6/10Timing: filed on 2026-10-15, same day as the reported purchase date

Background

The article is an SEC Form 4 insider transaction disclosure for FLSC, reporting an open-market purchase by the CEO via indirect holdings.

Company-level read

Ticker impact

$FLSCBullishMedium confidence
Context

SEC Form 4 shows CEO Cha Albert bought 300,000 shares of Frazier Life Sciences Acquisition Corp. II at $10.00/share on 2026-10-15.

Expected impact

Likely mild positive bias as traders price in insider confidence, but impact should be limited absent additional company-specific catalysts.

Evidence & confidence

This is a primary SEC insider transaction disclosure with a clear buy size and price, but it does not include new operating, financial, or deal information that would materially re-rate the company.

Market effects

Minimal, as this is a single-company insider transaction without sector-wide signals.

None indicated.

None indicated.

Counterpoint

Insider buys can be routine or driven by liquidity/compensation mechanics, so the signal may be weaker than it appears.

Key entities

  • Frazier Life Sciences Acquisition Corp. II

    Blank-check company whose CEO Cha Albert reported an insider purchase on SEC Form 4.

  • Cha Albert

    CEO, officer/director/10% owner, reported an indirect open-market purchase of 300,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles